Remifentanil Completed Phase 4 Trials for Respiratory Distress Syndrome Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care4
clinicaltrials.gov IdentifierTitleDrugs
NCT00391105Remifentanil Versus Morphine for Sedation of Premature Neonates With Respiratory Distress Syndrome